[This corrects the article DOI: 10.21037/jtd.2017.10.107.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344775 | PMC |
| http://dx.doi.org/10.21037/jtd.2018.11.11 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Author Correction: Rhinoviruses usurp STING for replication.
Nat Microbiol
September 2024
Virology Section, Division of Infectious Diseases & Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Author Correction: Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19.
Nat Commun
June 2023
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard-Strasse 9, 7265, Davos Wolfgang, Switzerland.
Correction to: Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases.
Inflammopharmacology
August 2022
School of Medicine, University of Tasmania, Hobart, TAS, 7000, Australia.
Corrigendum: Mechanism of Rhinovirus Immunity and Asthma.
Front Immunol
November 2021
Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.
[This corrects the article DOI: 10.3389/fimmu.2021.
View Article and Find Full Text PDFCorrection: Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist.
Genome Biol
November 2021
Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, People's Republic of China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!